WallStreetZenWallStreetZen

NASDAQ: REVB
Revelation Biosciences Inc Earnings & Revenue

REVB earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$120.3k
Current Profit Margin
0%

REVB Return on Equity

Current Company
-1.3%
Current Industry
-63.4%
Current Market
188%
REVB's Return on Equity (-1.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when REVB announces earnings.

REVB Return on Assets

Current Company
-0.8%
Current Industry
3.2%
REVB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

REVB Return on Capital Employed

Current Company
-1.81%
Current Industry
19.9%
REVB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

REVB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
REVB$0.00-$95.21k-$120.25kN/AN/A
PXMD$0.00-$18.28M-$18.29MN/AN/A
MYMD$0.00-$5.38M-$7.07M-100.00%N/A
GOVX$0.00-$25.89M-$25.97M-100.00%N/A
GNPX$0.00-$31.68M-$31.70MN/AN/A

REVB earnings dates

Next earnings date
May 20, 2024

Revelation Biosciences Earnings & Revenue FAQ

What were REVB's earnings last quarter?

On Invalid Date, Revelation Biosciences (NASDAQ: REVB) reported Q4 2023 earnings per share (EPS) of -$13.43, up 103.06% year over year. Total Revelation Biosciences earnings for the quarter were -$2.20 million. In the same quarter last year, Revelation Biosciences's earnings per share (EPS) was $439.10.

If you're new to stock investing, here's how to buy Revelation Biosciences stock.

What was REVB's earnings growth in the past year?

As of Q1 2024, Revelation Biosciences's earnings has grown year over year. Revelation Biosciences's earnings in the past year totalled -$120.25 thousand.

What is REVB's earnings date?

Revelation Biosciences's earnings date is Invalid Date. Add REVB to your watchlist to be reminded of REVB's next earnings announcement.

What was REVB's revenue last quarter?

On Invalid Date, Revelation Biosciences (NASDAQ: REVB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Revelation Biosciences's revenue was $0.00.

What was REVB's revenue growth in the past year?

As of Q1 2024, Revelation Biosciences's revenue has grown null year over year. Revelation Biosciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.